Implementing the Spotlight AQ Platform in Adolescent/ Young Adult (16-25 Years Old) Type 1 Diabetics (T1D) - Trial NCT06390371
Access comprehensive clinical trial information for NCT06390371 through Pure Global AI's free database. This phase not specified trial is sponsored by Children's Mercy Hospital Kansas City and is currently Recruiting. The study focuses on Type 1 Diabetes Mellitus. Target enrollment is 60 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Children's Mercy Hospital Kansas City
Timeline & Enrollment
N/A
Jun 06, 2024
Dec 01, 2024
Primary Outcome
HbA1c
Summary
The goal of this clinical trial is to compare the Spotlight AQ survey platform to the
 standard of care (SOC) pre-clinic assessment in adolescents & young adults (16-25 years old)
 with Type 1 Diabetes (T1D).
 
 The main questions it aims to answer are:
 
 - Does using the Spotlight AQ survey in clinic decrease the A1c in the people who use it?
 
 - Do patients and healthcare providers like using the spotlight AQ survey?
 
 Participants will use the Spotlight AQ survey before coming in to two standard of care T1D
 clinic visits Participants will fill out surveys describing how they feel about using the
 Spotlight AQ survey. Some participants may be asked to do an interview to talk about how they
 feel about the Spotlight AQ survey.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06390371
Non-Device Trial